{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:21:08Z","timestamp":1784676068942,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10384-018-0597-2","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T04:22:17Z","timestamp":1527654137000},"page":"409-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The National Registry of Retinoblastoma in Japan (1983\u20132014)"],"prefix":"10.1007","volume":"62","author":[{"name":"The Committee for the National Registry of Retinoblastoma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"key":"597_CR1","first-page":"1433","volume":"96","author":"The Committee for the National Registry of Retinoblastoma","year":"1992","unstructured":"The Committee for the National Registry of Retinoblastoma. National registry of retinoblastoma in Japan (1975\u20131982). Acta Soc Ophthalmol Jpn. 1992;96:1433\u201342.","journal-title":"Acta Soc Ophthalmol Jpn."},{"key":"597_CR2","first-page":"237","volume-title":"AJCC cancer staging manual","author":"American Joint Committee on Cancer","year":"1988","unstructured":"American Joint Committee on Cancer. AJCC cancer staging manual. 3rd ed. Philadelphia: Lippincott; 1988. p. 237\u201340.","edition":"3"},{"key":"597_CR3","first-page":"235","volume-title":"AJCC cancer staging manual","author":"American Joint Committee on Cancer","year":"1992","unstructured":"American Joint Committee on Cancer. AJCC cancer staging manual. 4th ed. Philadelphia: Lippincott; 1992. p. 235\u20138.","edition":"4"},{"key":"597_CR4","first-page":"269","volume-title":"AJCC cancer staging manual","author":"American Joint Committee on Cancer","year":"1997","unstructured":"American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997. p. 269\u201372.","edition":"5"},{"key":"597_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/978-1-4757-3656-4_44","volume-title":"AJCC cancer staging manual","author":"American Joint Committee on Cancer","year":"2002","unstructured":"American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. Berlin: Springer; 2002. p. 371\u20138.","edition":"6"},{"key":"597_CR6","unstructured":"Ministry of Health, Labour and Welfare. Vital statistics in Japan. 2017. \n                    http:\/\/www.e-stat.go.jp\/SG1\/estat\/NewListE.do?tid=000001028897\n                    \n                  . Accessed 15 Sept 2017."},{"key":"597_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/bjo.2008.138750","volume":"931","author":"E Broaddus","year":"2009","unstructured":"Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975\u20132004. Br J Ophthalmol. 2009;931:21\u20133.","journal-title":"Br J Ophthalmol."},{"key":"597_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/bjo.2008.139618","volume":"93","author":"A MacCarthy","year":"2009","unstructured":"MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, et al. Retinoblastoma in Great Britain 1963-2002. Br J Ophthalmol. 2009;93:33\u20137.","journal-title":"Br J Ophthalmol."},{"key":"597_CR9","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.ejca.2006.06.003","volume":"4213","author":"A MacCarthy","year":"2006","unstructured":"MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978\u20131997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;4213:2092\u2013102.","journal-title":"Eur J Cancer."},{"key":"597_CR10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ophtha.2003.10.023","volume":"111","author":"S Seregard","year":"2004","unstructured":"Seregard S, Lundell G, Svedberg H, Kivel\u00e4 T. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantage of birth cohort analysis. Ophthalmology. 2004;111:1128\u201332.","journal-title":"Ophthalmology."},{"key":"597_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/APO.0000000000000060","volume":"3","author":"RH Usmanov","year":"2014","unstructured":"Usmanov RH, Kivel\u00e4 T. Predicted trends in the incidence of retinoblastoma in the Asia-Pacific region. Asia Pac J Ophthalmol (Phila). 2014;3:151\u20137.","journal-title":"Asia Pac J Ophthalmol (Phila)."},{"key":"597_CR12","first-page":"73","volume-title":"Cancer incidence and survival among children and adolescents: United States SEER Program 1975\u20131995","author":"JL Young","year":"1999","unstructured":"Young JL, Smith MA Jr, Roffers SD, Liff JM, Bunin GR. Retinoblastoma. In: Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975\u20131995. Bethesda: National Cancer Institute; 1999. p. 73."},{"key":"597_CR13","unstructured":"National Institutes of Health. Retinoblastoma. 2017. \n                    https:\/\/ghr.nlm.nih.gov\/condition\/retinoblastoma\n                    \n                  . Accessed 8 May 2018."},{"key":"597_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00295569","volume":"52","author":"F Vogel","year":"1979","unstructured":"Vogel F. Genetics of retinoblastoma. Hum Genet. 1979;52:1\u201354.","journal-title":"Hum Genet."},{"key":"597_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.21037\/atm.2016.05.05","volume":"4","author":"AE Stark","year":"2016","unstructured":"Stark AE. Determining the incidence of the hereditary form of retinoblastoma. Ann Transl Med. 2016;4:171.","journal-title":"Ann Transl Med."},{"key":"597_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5005\/jp\/books\/11629_4","volume-title":"retinoblastoma","author":"A Ganguly","year":"2012","unstructured":"Ganguly A, Nichols KE. Genetics of retinoblastoma: molecular and clinical aspects. In: Ramasubramanian A, Shields CA, editors. retinoblastoma. New Delhi: Jaypee Brothers Medical Publishers; 2012. p. 24\u201336."},{"key":"597_CR17","unstructured":"Lohmann DR, Gallie BL. Retinoblastoma. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews\u00ae [Internet]. Seattle, WA: University of Washington, Seattle; 2015."},{"key":"597_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0022-3476(98)70028-9","volume":"132","author":"DH Abramson","year":"1998","unstructured":"Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, Boyd NW 3rd. Presenting signs of retinoblastoma. J Pediatr. 1998;132:505\u20138.","journal-title":"J Pediatr."},{"key":"597_CR19","unstructured":"American Academy of Ophthalmology. Retinoblastoma-Asia Pacific. 2013. \n                    https:\/\/www.aao.org\/topic-detail\/retinoblastoma\u2013asia-pacific\n                    \n                  . Accessed Nov 2013."},{"key":"597_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.12968\/ijop.2014.5.6.218","volume":"5","author":"P Singla","year":"2014","unstructured":"Singla P, Ley-Smith R, Maxwell P. Importance of the red reflex test in the diagnosis of eye cancer. Int J Ophthalmic Pract 2014; 5:218\u2013221.","journal-title":"Int J Ophthalmic Pract"},{"key":"597_CR21","first-page":"36","volume":"27","author":"National Center for Biotechnology Information","year":"2014","unstructured":"National Center for Biotechnology Information. How to test for the red reflex in a child. Community Eye Health. 2014;27:36.","journal-title":"Community Eye Health."},{"key":"597_CR22","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/archopht.122.9.1316","volume":"122","author":"DH Abramson","year":"2004","unstructured":"Abramson DH, Beaverson KL, Chang ST, Dunkel IJ, McCormick B. Outcome following initial external beam radiotherapy in patients with Reese\u2013Ellsworth group Vb retinoblastoma. Arch Ophthalmol. 2004;122:1316\u201323.","journal-title":"Arch Ophthalmol."},{"key":"597_CR23","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1200\/JCO.2005.05.054","volume":"23","author":"RA Kleinerman","year":"2005","unstructured":"Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005;23:2272\u20139.","journal-title":"J Clin Oncol."},{"key":"597_CR24","first-page":"1262","volume":"278","author":"FL Wong","year":"1997","unstructured":"Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278:1262\u20137.","journal-title":"Radiation dose and sarcoma risk. JAMA."},{"key":"597_CR25","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/archopht.116.7.887","volume":"116","author":"NE Bechrakis","year":"1998","unstructured":"Bechrakis NE, Bornfeld N, Schueler A, Coupland SE, Henze G, Foerster MH. Clinicopathologic features of retinoblastoma after primary chemoreduction. Arch Ophthalmol. 1998;116:887\u201393.","journal-title":"Arch Ophthalmol."},{"key":"597_CR26","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1001\/archopht.116.12.1613","volume":"116","author":"K G\u00fcnd\u00fcz","year":"1998","unstructured":"G\u00fcnd\u00fcz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, et al. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Arch Ophthalmol. 1998;116:1613\u20137.","journal-title":"Arch Ophthalmol."},{"key":"597_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1200\/JCO.2000.18.1.12","volume":"18","author":"DL Friedman","year":"2000","unstructured":"Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18:12\u20137.","journal-title":"J Clin Oncol."},{"key":"597_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ajo.2004.04.032","volume":"138","author":"CL Shields","year":"2004","unstructured":"Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138:329\u201337.","journal-title":"Am J Ophthalmol"},{"key":"597_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/aos.12282","volume":"92","author":"K Bartuma","year":"2014","unstructured":"Bartuma K, Pal N, Kosek S, Holm S, All-Ericsson C. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma. Acta Ophthalmol. 2014;92:404\u201311.","journal-title":"Acta Ophthalmol."},{"key":"597_CR30","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.ophtha.2016.05.034","volume":"123","author":"B Chawla","year":"2016","unstructured":"Chawla B, Hasan F, Seth R, Pathy S, Pattebahadur R, Sharma S, et al. Multimodal therapy for Stage III retinoblastoma (International Retinoblastoma Staging System): a prospective comparative study. Ophthalmology. 2016;123:1933\u20139.","journal-title":"Ophthalmology."},{"key":"597_CR31","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","volume":"118","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 2011;118:2081\u20137.","journal-title":"Ophthalmology."},{"key":"597_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s10384-015-0378-0","volume":"59","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, Aihara Y, Fujiwara M, Sano S, Kaneko A. Intravitreal injection of melphalan for intraocular retinoblastoma. Jpn J Ophthalmol. 2015;59:164\u201372.","journal-title":"Jpn J Ophthalmol."},{"key":"597_CR33","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","volume":"129","author":"CL Shields","year":"2011","unstructured":"Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129:1399\u2013406.","journal-title":"Arch Ophthalmol."},{"key":"597_CR34","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","volume":"121","author":"CL Shields","year":"2014","unstructured":"Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, et al. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma. Ophthalmology. 2014;121:1453\u201360.","journal-title":"Ophthalmology."},{"key":"597_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/eye.2012.175","volume":"27","author":"CL Shields","year":"2013","unstructured":"Shields CL, Fulco EM, Arias JD, Alarcon C, Pellegrini M, Rishi P, et al. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond). 2013;27:253\u201364.","journal-title":"Eye (Lond)."},{"key":"597_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","volume":"132","author":"CL Shields","year":"2014","unstructured":"Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results. JAMA Ophthalmol. 2014;132:319\u201325.","journal-title":"JAMA Ophthalmol."},{"key":"597_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10384-014-0356-y","volume":"59","author":"SJ Ong","year":"2015","unstructured":"Ong SJ, Chao AN, Wong HF, Liou KL, Kao LY. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review. Jpn J Ophthalmol. 2015;59:109\u201317.","journal-title":"Jpn J Ophthalmol."},{"key":"597_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/13816818709028518","volume":"8","author":"J Hungerford","year":"1987","unstructured":"Hungerford J, Kingston J, Plowman N. Orbital recurrence of retinoblastoma. Ophthalmic Pediatr Genet. 1987;8:63\u20138.","journal-title":"Ophthalmic Pediatr Genet."},{"key":"597_CR39","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0161-6420(03)00669-9","volume":"110","author":"TC Lee","year":"2003","unstructured":"Lee TC, Hayashi NI, Dunkel IJ, Beaverson K, Novetsky D, Abramson DH. New retinoblastoma tumor formation in children initially treated with systemic carboplatin. Ophthalmology. 2003;110:1989\u201394 (discussion 1994\u20135).","journal-title":"Ophthalmology."},{"key":"597_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/13816810.2011.610859","volume":"33","author":"HV Tran","year":"2012","unstructured":"Tran HV, Schorderet DF, Gaillard MC, Balmer A, Munier FL. Risk assessment of recurrence in sporadic retinoblastoma using a molecular-based algorithm. Ophthalmic Genet. 2012;33:6\u201311.","journal-title":"Ophthalmic Genet."},{"key":"597_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/bjo.2008.143842","volume":"93","author":"E Broaddus","year":"2009","unstructured":"Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975\u20132004. Br J Ophthalmol. 2009;93:24\u20137.","journal-title":"Br J Ophthalmol."},{"key":"597_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/bjo.2008.139626","volume":"93","author":"A MacCarthy","year":"2009","unstructured":"MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, et al. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002. Br J Ophthalmol. 2009;93:38\u20139.","journal-title":"Br J Ophthalmol."}],"updated-by":[{"DOI":"10.1007\/s10384-018-0606-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000}}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-018-0597-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-018-0597-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-018-0597-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T23:19:04Z","timestamp":1559171944000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-018-0597-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1007\/s10384-018-0597-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10384-018-0606-5","asserted-by":"object"}]},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Committee for the National Registry of Retinoblastoma.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N. Azuma, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}